BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26373456)

  • 21. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
    PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.
    Peng DF; Hu TL; Soutto M; Belkhiri A; El-Rifai W
    Carcinogenesis; 2014 Jul; 35(7):1620-8. PubMed ID: 24692067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa.
    von Rahden BH; Kircher S; Kafka M; Stuermer L; Reiber C; Gattenlöhner S; Germer CT; Grimm M
    Cancer Biomark; 2010; 7(6):285-94. PubMed ID: 21694467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms.
    Clemons NJ; McColl KE; Fitzgerald RC
    Gastroenterology; 2007 Oct; 133(4):1198-209. PubMed ID: 17919494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.
    Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R
    Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett's Esophagus Compared to Esophageal Adenocarcinoma.
    O'Farrell NJ; Phelan JJ; Feighery R; Doyle B; Picardo SL; Ravi N; O'Toole D; Reynolds JV; O'Sullivan J
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma.
    Rizk NP; Servais EL; Tang LH; Sima CS; Gerdes H; Fleisher M; Rusch VW; Adusumilli PS
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):482-6. PubMed ID: 22237988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
    Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
    Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.
    Dvorak K; Watts GS; Ramsey L; Holubec H; Payne CM; Bernstein C; Jenkins GJ; Sampliner RE; Prasad A; Garewal HS; Bernstein H
    Am J Gastroenterol; 2009 Feb; 104(2):302-9. PubMed ID: 19174784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.
    Vega KJ; May R; Sureban SM; Lightfoot SA; Qu D; Reed A; Weygant N; Ramanujam R; Souza R; Madhoun M; Whorton J; Anant S; Meltzer SJ; Houchen CW
    J Gastroenterol Hepatol; 2012 Apr; 27(4):773-80. PubMed ID: 21916995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
    O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
    BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barrett's Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models.
    Korbut E; Krukowska K; Magierowski M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.
    Molendijk J; Nguyen TM; Brown I; Mohamed A; Lim Y; Barclay J; Hodson MP; Hennessy TP; Krause L; Morrison M; Hill MM
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32429496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis.
    Arcidiacono D; Antonello A; Fassan M; Nucci D; Morbin T; Agostini M; Nitti D; Rugge M; Alberti A; Battaglia G; Realdon S
    Dig Liver Dis; 2017 Jun; 49(6):630-638. PubMed ID: 28185837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
    Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile acids but not acidic acids induce Barrett's esophagus.
    Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
    Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.
    Ballout F; Lu H; Chen L; Sriramajayam K; Que J; Meng Z; Wang TC; Giordano S; Zaika A; McDonald O; Peng D; El-Rifai W
    J Exp Clin Cancer Res; 2022 Sep; 41(1):264. PubMed ID: 36045416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells.
    Li D; Cao W
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G863-72. PubMed ID: 24699332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.